Coke Built It. Pepsi Bought It.
A jab step costs the attacker a step and the defender his balance. Two prebiotic soda startups raised under $100 million between them and made Coca-Cola and PepsiCo commit. One built. One bought for $1.95 billion. The third answer belonged to the challenger.
Carmelo Anthony was the NBA's scoring champion in 2013, averaging 28.7 points a game, and he still holds the New York Knicks' single-game record of 62. He was known for strength, quickness and a variety of crafty moves close to the basket. One move built for exactly that spot is the jab step: a short, sharp step toward the defender that looks like the first step of a drive.
The move costs the attacker almost nothing. He has not committed his weight. The defender has no such luxury. People take about 190 milliseconds on average just to react to something they see, and the time grows as the number of things that might happen grows. A player facing someone who can shoot, drive left or drive right has to prepare for all three, and a convincing fake forces him to commit his weight to one before he knows which is real. The attacker spends a step. The defender spends his balance.
Challenger brands do this to the largest companies in their category. Prebiotic soda is the clearest recent case, because the incumbents' answers are on the record.
A small bet that forced a large one
Poppi began in Houston as Mother Beverage, an apple cider vinegar drink. It took $400,000 on Shark Tank in 2018, rebranded as Poppi in 2020, and raised a $13.5 million Series A in 2021 and a $25 million Series B in 2022. Olipop, founded the same year, had raised $55.4 million in total by January 2023. Between them, well under $100 million of disclosed venture money.
By 2023 both were past $100 million in revenue. Olipop reported $100 million in gross revenue in the first half of that year alone, and its root beer outsold A&W's. Two small companies had opened a category on the soda shelf, in the space Coca-Cola and PepsiCo consider theirs. Each incumbent had to decide how much weight to commit.
Poppi's two disclosed venture rounds, 2021–2022, against what PepsiCo agreed to pay for it in March 2025. The headline price includes about $300 million of expected tax benefits; the net figure is reported as a little over $1.6 billion. Either way, forty to fifty times what the challenger raised.
Three answers to the same fake
| Company | The call | When | What it commits |
|---|---|---|---|
| PepsiCo | Buy the leader, poppi | Announced March 2025; closed May 19, 2025 | $1.95B headline; the brand, its demand and its legal history |
| Coca-Cola | Build: Simply Pop, prebiotic sodas under the Simply brand | 2025; named in Coca-Cola's first-quarter 2025 results | A line extension on an existing, trusted brand; no demand of its own on day one |
| Olipop | Stay independent | $50M Series C, February 2025, at a $1.85B valuation | Keeps competing with both incumbents; reported as profitable by then |
Sources: Wikipedia entries for Poppi (drink), Olipop, PepsiCo and the Simply Orange Juice Company, retrieved September 26, 2026. Coca-Cola's first-quarter 2025 earnings release (filed with the SEC as an 8-K exhibit on April 29, 2025, accession 0000021344-25-000024) names Simply Pop. Coca-Cola does not report Simply Pop's sales separately.
PepsiCo committed its full weight. It paid forty to fifty times the challenger's venture funding and got speed: a brand with demand already built, and the leading position in the category on the day the deal closed. It also got the brand's history. In 2024 a California class action argued that one can held too little prebiotic fiber to deliver the gut benefit the marketing implied. The company agreed in July 2025 to settle for $8.9 million, without admitting wrongdoing.
Coca-Cola kept its weight back. Simply Pop cost a line extension under a name shoppers already trust for juice. It is cheap, and it can be quietly withdrawn if it fails. What it did not buy is a head start. Poppi and Olipop spent years building the pull that keeps a product on a shelf; Simply Pop started without it.
Olipop took the third option, one only the challenger had. It raised again at a valuation just below what PepsiCo paid for its rival, and kept both incumbents guessing.
What PepsiCo bought, seen from abroad
2026In 2026, PepsiCo's British bottler, Carlsberg Britvic, launched poppi in the UK and Ireland, in Tesco and Pret a Manger. It is not marketed there as a prebiotic soda: the UK version does not contain enough fiber to make the claim. The brand traveled. The claim did not.
PepsiCo's $1.95 billion bought a brand and an occasion people reach for. The health claim was the part that could not be taken across a border.
Who was right is not answerable yet
Nobody outside the two companies knows. PepsiCo does not break out poppi's sales in its filings, and Coca-Cola does not break out Simply Pop's. The fair test is shelf position and share over 2026 and 2027, and I will check both answers against what the companies and retailers report by September 2027.
What can be said now is what each answer risks. A buy that overpays cannot be undone. A build that arrives without demand can sit on the shelf and be delisted without anyone noticing. Both are rational. They are bets on different things: PepsiCo that the category's demand is real and already owned by someone, Coca-Cola that a trusted name can catch up.
What this means if you are the challenger
The jab step works because the attacker keeps his options live and the defender cannot. A challenger's options are the same three the incumbents faced from the other side: keep growing and stay independent, be copied, or be bought. The founders who get to choose among them are the ones who built demand an incumbent can see in its own numbers, and whose claims hold up when a lawyer or a foreign regulator reads the can.
Most challengers never force the question. They are ignored rather than copied or bought, because nothing they do shows up in the incumbent's numbers. The fake only works if it looks like a real drive.
- The incumbents have noticed. One has launched a copy, bid for a rival, or named your category in its results.
- You have demand of your own. People ask for you by name, and a retailer would miss you if you left.
- Your claims hold up. What the pack says survives a court and a different country's rules.
- You can afford to wait. Enough runway to stay independent if neither the offer nor the copy comes on your timetable.
- Not yours if no incumbent has moved yet. Then the job is building demand, and talk of an exit is a distraction.
Write down the three responses your largest incumbent could make to you (ignore, copy, buy) and the signal that would tell you each one has started.
For each response, one line on what you would do and one on what you would see first. A copy usually shows up as a new product in your top retailers or a trademark filing. A buy starts with a meeting request that is not about distribution. Being ignored shows up as nothing, which is why it needs a date: if none of the signals appear within four quarters, your demand is not yet visible in their numbers.
- What it costs
- Three hours with your co-founder or lead investor, and the discomfort of deciding in advance what you would say to an offer.
- How you'll know
- Within the quarter you can say which of the three responses you are getting. If you can't, you are being ignored, and the plan for the next four quarters is demand.
Related from Sound Decisions: Poppi Didn’t Go Viral by Accident · The Ground Nobody Was Defending · City Stopped Tuning and Bought a Finisher
Is an incumbent watching you yet? Get a read on it.
A sourced, dated read of your category: which incumbents have moved, what they committed, and what that signals about your options. Ask, and I'll run one.
Request a read